Professor Colm Bergin
CONSULTANT PHYSICIAN /Clinical Professor, Clinical Medicine
Biography
Professor Bergin is a Consultant Physician and Academic Lead in Infectious Diseases, St James's Hospital, Dublin and Professor of Medicine at Trinity College Dublin. His clinical and research expertise is focussed on chronic viral infections and their treatment outcomes, health services research with particular interests in complications associated with HIV-HCV co-infection, health-related outcomes, medical education, clinical trials and pharmacological and non-pharmacological treatment interventions. Professor Bergin developed the clinical specialty of Infectious Diseases at St James's Hospital and integrated the specialty with the previously established Department of Genitourinary Medicine. He has led the political advocacy to establish the field of social inclusion health and in advocating for patients from underserved and disadvantaged populations. Professor Bergin's Directorships encompass his role as Associate Director of the Wellcome - Health Research Board (HRB) Clinical Research Facility and Clinical Director of the Surgical and Medical Subspecialties Directorate at St. James's Hospital. Professor Bergin's holds an outstanding track record in academia and scientific research. His lifelong career has been dedicated to clinical and translational investigations into the causes and etiology of serious infectious diseases such as HIV, SARS and Covid. With over 200 peer reviewed articles and four book chapters which have been widely cited worldwide, he has made an important contribution to furthering the understanding of infection and viruses. Professor Bergin has secured over €20 million grant funding from Irish and International funding sponsors to support his research work. Professor Bergin is a dedicated teacher and has mentored a diverse portfolio of candidates to successful completion of MSc, MD and PhD degrees covering research topics in medical education; cost effectiveness of medical care (HIV and HCV); molecular and clinical epidemiology; immunology of host response to infections (TB and HCV); neurocognitive disease in HIV, HCV and COVID-19 infections and innovative interventions to affect social behaviours in disease modelling. Professor Bergin graduated from Trinity College Dublin in 1989 and completed General Medicine and Specialist Training. Subsequently, Professor Bergin completed a Fellowship in Infectious Diseases at Boston University Hospital (1996-1999) and returned to Dublin in 1999 when he was appointed to his present consultant position in St. James's Hospital. Professor Bergin has worked in Blackrock Clinic since 2002. Prior leadership appointments have included National Clinical Lead, Infectious Diseases, HSE (2020-2022); Associate Director of the Wellcome-Health Research Board (HRB) Clinical Research Facility, St. James's Hospital Dublin and Interim Director, CRF (2012-2017); National Specialty Director, Infectious Diseases, Royal College of Physicians Ireland (RCPI) (2002-2017); Dean of Postgraduate Medical Training and Dun's Tutor, RCPI (2012-2015); Clinical Director of the Surgical and Medical Subspecialties Directorate, St. James's Hospital, Dublin (2006-2012); President of the Infectious Diseases Society of Ireland (IDSI) (2009-2012) and National Programme Lead for OPAT, Health Services Executive, Ireland (2010-2012). Other roles include co-Founding lead and past chair of the Irish Hepatitis C Research Outcomes Network (ICORN); Chair, Therapeutic Advisory Committee for COVID-19, HSE; Member, NPHET, DoH; Director, Hospital Site Accreditation, Royal College of Physicians (RCPI) (2017-2019) and Vice-President, RCPI.
Publications and Further Research Outputs
Peer-Reviewed Publications
Gerry Hughes, Eilis O" Toole, Una Coleman, Alida Fe Talento, Keith Doyle, Aisling O" Leary, Colm Bergin, Beyond consumption: a qualitative investigation of hospital clinician attitudes to receiving feedback on antimicrobial prescribing quality, Antimicrobial Stewardship and Healthcare Epidemiology, 2, (1), 2022
Allen, Niamh and Brady, Melissa and Ni Riain, Una and Conlon, Niall and Domegan, Lisa and Carrion Martin, Antonio Isidro and Walsh, Cathal and Doherty, Lorraine and Higgins, Eibhlin and Kerr, Colm and others, Prevalence of antibodies to SARS-CoV-2 following natural infection and vaccination in Irish hospital healthcare workers: changing epidemiology as the pandemic progresses, Frontiers in Medicine, 8, 2022, p758118
Kelly K O'Brien, Darren A Brown, Colm Bergin, Kristine M Erlandson, Jaime H Vera, Lisa Avery, Soo Chan Carusone, Angela M Cheung, Susie Goulding, Richard Harding, Lisa McCorkell, Margaret O'Hara, Larry Robinson, Catherine Thomson, Hannah Wei, Natalie St Clair-Sullivan, Brittany Torres, Ciaran Bannan, Niamh Roche, Ruth Stokes, Patriic Gayle, Patricia Solomon, Long COVID and episodic disability: advancing the conceptualisation, measurement and knowledge of episodic disability among people living with Long COVID " protocol for a mixed-methods study, BMJ Open, 12, (3), 2022, pe060826
Kelly K O'Brien, Patricia Solomon, Soo Chan Carusone, Kristine M Erlandson, Colm Bergin, Ahmed M Bayoumi, Steven E Hanna, Richard Harding, Darren A Brown, Jaime H Vera, Marta Boffito, Carolann Murray, Rachel Aubry, Noreen O'Shea, Natalie St Clair-Sullivan, Mallory Boyd, Marilyn Swinton, Brittany Torres, Aileen M Davis, Assessing the sensibility and utility of a short-form version of the HIV Disability Questionnaire in clinical practice settings in Canada, Ireland and the USA: a mixed methods study, BMJ Open, 2022
Thomas Phelan, Jean Dunne, Niall Conlon, Clíona Ní Cheallaigh, W. Mark Abbott, Raquel Faba-Rodriguez, Fatima Amanat, Florian Krammer, Mark A. Little, Gerry Hughes, Colm Bergin, Colm Kerr, Sudharshana Sundaresan, Aideen Long, William McCormack, Gareth Brady, Dynamic Assay for Profiling Anti-SARS-CoV-2 Antibodies and Their ACE2/Spike RBD Neutralization Capacity, Viruses, 13, (7), 2021, p1371
Townsend L, Dowds J, O'Brien K, Sheill G, Dyer AH, O'Kelly B, Hynes JP, Mooney A, Dunne J, Ni Cheallaigh C, O'Farrelly C, Bourke NM, Conlon N, Martin-Loeches I, Bergin C, Nadarajan P, Bannan C., Persistent Poor Health Post-COVID-19 Is Not Associated with Respiratory Complications or Initial Disease Severity., Annals of the American Thoracic Society, 2021
Allen, Niamh and Brady, Melissa and Carrion Martin, Antonio Isidro and Domegan, Lisa and Walsh, Cathal and Houlihan, Elaine and Kerr, Colm and Doherty, Lorraine and King, Joanne and Doheny, Martina and others, SARS-CoV-2 antibody testing in health care workers: a comparison of the clinical performance of three commercially available antibody assays, Microbiology Spectrum, 9, (2), 2021, pe00391--21
Liam Townsend, Adam H Dyer, Aifric Naughton, Rachel Kiersey, Dean Holden, Mary Gardiner, Joanne Dowds, Kate O'Brien, Ciaran Bannan, Parthiban Nadarajan, Jean Dunne, Ignacio Martin-Loeches, Padraic Fallon, Colm Bergin, Cliona O'Farrelly, Cliona Ni Cheallaigh, Nollaig Bourke, Niall Conlon, Longitudinal analysis of COVID-19 patients shows age-associated T cell changes independent of ongoing ill-health, Frontiers In Immunology, 2021
Kerr C, Dunne J, Hughes G, Cox F, Healy M, Holmes P, O'Rourke F, O'Brien C, Coyne D, Crowley V, Crowley B, Conlon N, Bergin C, A Comparison of the Performance of SARS-CoV-2 Antibody Assays in Healthcare Workers with COVID-19., Irish medical journal, 2021
Kerr C, O' Regan S, Creagh D, Hughes G, Geary U, Colgan MP, Canning C, Martin Z, Merry C, Noonan N, Bergin C, Acceptability of and symptom findings from an online symptom check-in tool for COVID-19 outpatient follow-up among a predominantly healthcare worker population., BMJ open, 2021
Allen N, Ni Riain U, Conlon N, Ferenczi A, Carrion Martin AI, Domegan L, Walsh C, Doherty L, O'Farrelly C, Higgins E, Kerr C, McGrath J, PRECISE Study Steering Group, Fleming C, Bergin C., Prevalence of Antibodies to SARS-CoV-2 in Irish Hospital Healthcare Workers., Epidemiology and infection, 2021, p1-33
Allen, Niamh and Brady, Melissa and Martin, Antonio Isidro Carrion and Domegan, Lisa and Walsh, Cathal and Doherty, Lorraine and Riain, Una Ni and Bergin, Colm and Fleming, Catherine and Conlon, Niall, Serological markers of SARS-CoV-2 infection; anti-nucleocapsid antibody positivity may not be the ideal marker of natural infection in vaccinated individuals, Journal of Infection, 83, (4), 2021, pe9--e10
Townsend, L. and Moloney, D. and Finucane, C. and McCarthy, K. and Bergin, C. and Bannan, C. and Kenny, R.-A., Fatigue following COVID-19 infection is not associated with autonomic dysfunction, PLoS ONE, 16, (2 February 2021), 2021
Townsend L, Fogarty H, Dyer A, Martin-Loeches I, Bannan C, Nadarajan P, Bergin C, O' Farrelly C, Conlon N, Bourke NM, Ward SE, Byrne M, Ryan K, O' Donnell JS, Prolonged elevation of D-dimer Levels in Convalescent COVID-19 patients is Independent of the Acute Phase Response., Journal of thrombosis and haemostasis : JTH, 2021
Kerr C, Allen N, Hughes G, Kelly M, O'Rourke F, Lynagh Y, Dunne J, Crowley B, Conlon N, Bergin C, SARS-CoV-2 anti-nucleocapsid assay performance in healthcare workers at baseline and 6 months., Irish journal of medical science, 2021
Grant C, O'Connell S, Lillis D, Moriarty A, Fitzgerald I, Dalby L, Bannan C, Tuite H, Crowley B, Plunkett P, Kennedy U, McMahon G, McKiernan S, Norris S, Hughes G, Shields D, Bergin C, Opt-out screening for HIV, hepatitis B and hepatitis C: observational study of screening acceptance, yield and treatment outcomes, Emerg Med J, 2019
O'Connell S, Lillis D, Cotter A, O'Dea S, Tuite H, Fleming C, Crowley B, Fitzgerald I, Dalby L, Barry H, Shields D, Norris S, Plunkett PK, Bergin C., Opt-Out Panel Testing for HIV, Hepatitis B and Hepatitis C in an Urban Emergency Department: A Pilot Study, PLoS One, 11, (3), 2016
Kieran JA, Norris S, O'Leary A, Walsh C, Merriman R, Houlihan D, McCormick PA, McKiernan S, Bergin C, Barry M, Hepatitis C in the era of direct-acting antivirals: real-world costs of untreated chronic hepatitis C; a cross-sectional study., BMC infectious diseases, 15, 2015, p471
S O'Connell, Lillis D, O'Dea S, H Tuite, C Fleming, D Shields, S Norris, B Crowley. P Plunkett, C Bergin , Results of a Universal Testing Programme for Blood Borne Viruses in an Urban Emergency Department, including Rates of Diagnosis and Linkage to Care, AASLD The Liver Meeting, Boston, MA, November 7-11 2014, 2014
Morley D, McNamara P, Kennelly S, McMahon G, Bergin C, Limitations to the identification of HIV-associated neurocognitive disorders in clinical practice., HIV medicine, 14, (8), 2013, p497-502
Kieran J, Schmitz S, O'Leary A, Walsh C, Bergin C, Norris S, Barry M, The relative efficacy of boceprevir and telaprevir in the treatment of hepatitis C virus genotype 1., Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 56, (2), 2013, p228-35
Ní Cheallaigh C, Fitzgerald I, Grace J, Jagjit Singh G, El-Eraki N, Gibbons N, Keane J, Rogers TR, Clarke S, Bergin C, Interferon Gamma Release Assays for the Diagnosis of Latent TB Infection in HIV-Infected Individuals in a Low TB Burden Country., PloS one, 8, (1), 2013, pe53330
P. McNamara, J. Redmond, C. Bergin, C. Doherty, The Case for Cognitive Screening in HIV Clinics, Irish Medical Journal, 2012, 244, 245
Breslin TM, Ionmhain UN, Bergin C, Gallagher D, Collins N, Kinsella N, McMahon G, Malarial cases presenting to a European urban Emergency Department., European Journal of Emergency Medicine : official journal of the European Society for Emergency Medicine, 2012
De Gascun CF, Waters A, Regan CM, O'Halloran J, Farrell G, Coughlan S, Bergin C, Powderly WG, Hall WW, Human Immunodeficiency Virus Type 1 in Ireland: Phylogenetic Evidence for Risk Group-Specific Subepidemics., AIDS Research and Human Retroviruses, 2012
Dillon AA, Farrell G, Hegarty JE, O'Grady JG, Norris S, Bergin C, The advent of successful organ transplantation in the Irish HIV positive cohort., Irish Journal of Medical Science, 181, (1), 2012, p49-52
De Gascun CF, Waters A, Regan C, O'Halloran J, Farrell G, Coughlan S, Bergin C, Powderly WG, Hall WW, Documented prevalence of HIV type 1 antiretroviral transmitted drug resistance in Ireland from 2004 to 2008., AIDS Research and Human Retroviruses, 28, (3), 2012, p276-81
S. Edwards, C. Bergin, R. Miller, Pyrexia of Unknown Origin. BHIVA and BIS Association Guidelines for the Treatment of Opportunistic Infection in HIV Seropositive Individuals , HIV Medicine , 12, 2011, p83 - 87
Kennedy A, Hennessy M, Bergin C, Mulcahy F, Hopkins S, Spiers JP, Ribavirin and interferon alter MMP-9 abundance in vitro and in HIV-HCV-coinfected patients., Antiviral therapy, 16, (8), 2011, p1237-47
Kieran J, Dillon A, Farrell G, Jackson A, Norris S, Mulcahy F, Bergin C, High uptake of hepatitis C virus treatment in HIV/hepatitis C virus co-infected patients attending an integrated HIV/hepatitis C virus clinic., International journal of STD & AIDS, 22, (10), 2011, p571-6
Dunn K, O'Reilly A, Silke B, Rogers T, Bergin C, Implementing a pharmacist-led sequential antimicrobial therapy strategy: a controlled before-and-after study., International Journal of Clinical Pharmacy, 33, (2), 2011, p208-14
E. McCarthy, E. deBarra, C. Bergin, G. Cunnane, M. Doran, Rates of Influenza and Pneumococcal Vaccination and Varicella Immune Status in patients with Inflammatory Arthritis., IMJ , 104, 2011, p208 - 211
McCarthy EM, de Barra E, Bergin C, Cunnane G, Doran M, Influenza and pneumococcal vaccination and varicella status in inflammatory arthritis patients., Irish Medical Journal, 104, (7), 2011, p208-11
Nelson M, Dockrell D, Edwards S, Angus B, Barton S, Beeching N, Bergin C, Boffito M, Breen R, Cartledge J, Clarke S, Fisher M, Freedman A, Gazzard B, Grant A, Greig J, Jones R, Khoo S, Leen C, Lipman M, Manji H, Miller R, Mitchell S, Ong E, Pozniak A, Schmid M, Shiew M, Singer M, Wilkins E, Williams I, Wood C, Weston R, British HIV Association and British Infection Association guidelines for the treatment of opportunistic infection in HIV-seropositive individuals 2011., HIV Medicine, 12 Suppl 2, 2011, p1-140
A Kennedy, M Hennessy, C. Bergin, F Mulcahy, S. Hopkins, JP Spiers, Ribavirin and interferon Reduce MMP-9 in HIV/HCV patients: Implications for Liver Pathology, Antiviral Therapy , 16, 2011, p1237 - 1247
Muldoon EG, Hogan A, Kilmartin D, McNally C, Bergin C, Syphilis consequences and implications in delayed diagnosis: five cases of secondary syphilis presenting with ocular symptoms., Sexually Transmitted Infections, 86, (7), 2010, p512-3
Kiely B, O'Flaherty J, Surah S, Kieran J, O'Donnell D, Bergin C, Mulcahy F, HIV-related malignancies pre- and post-highly active antiretroviral therapy: experiences in an inner city tertiary referral centre., International Journal of STD & AIDS, 21, (5), 2010, p332-6
Brook G, Soriano V, Bergin C, European guideline for the management of hepatitis B and C virus infections, 2010., International Journal of STD & AIDS, 21, (10), 2010, p669-78
Feeney S, Muldoon E, Barrett P, Martos R, Mulvihill N, O'Flanagan D, Bergin C, Varicella infection and the impact of late entry into the Irish healthcare system., Journal of Infection and Public Health, 3, (3), 2010, p106-12
Orkin C, Wang J, Bergin C, Molina JM, Lazzarin A, Cavassini M, Esser S, Gómez Sirvent JL, Pearce H, An epidemiologic study to determine the prevalence of the HLA-B*5701 allele among HIV-positive patients in Europe., Pharmacogenetics and Genomics, 20, (5), 2010, p307-14
Roe B, Coughlan S, Dean J, Lambert JS, Keating S, Norris S, Bergin C, Hall WW, Phenotypic characterization of lymphocytes in HCV/HIV co-infected patients., Viral immunology, 22, (1), 2009, p39-48
S. Hopkins, C. Bergin, F. Mulcahy, HIV Status does not contribute to response to Syphilis treatment , 2009
McGowan B, Bergin C, Bennett K, Barry M, Utilisation of antibiotic therapy in community practice., Irish medical journal, 101, (9), 2008, p273-6
Roe B, Coughlan S, Hassan J, Grogan A, Farrell G, Norris S, Bergin C, Hall WW, Elevated serum levels of interferon- gamma -inducible protein-10 in patients coinfected with hepatitis C virus and HIV., The Journal of infectious diseases, 196, (7), 2007, p1053-7
Kevans D, Farrell G, Hopkins S, Mahmud N, White B, Norris S, Bergin C, Haematological support during peg-interferon therapy for HCV-infected haemophiliacs improves virological outcomes., Haemophilia : the official journal of the World Federation of Hemophilia, 13, (5), 2007, p593-8
A Jackson, C Bergin., Sexual Health in Men. , Clinical Focus Supplement. Forum Magazine., 2007
Murray-Lillibridge K, Barry J, Reagan S, O'flanagan D, Sayers G, Bergin C, Keenan E, O'briain S, Plunkett P, McMahon G, Keane C, O'sullivan P, Igoe D, Mullen L, Ward M, Smith A, Fischer M, Epidemiological findings and medical, legal, and public health challenges of an investigation of severe soft tissue infections and deaths among injecting drug users -- Ireland, 2000., Epidemiology and infection, 134, (4), 2006, p894-901
Hopkins S, Lambourne J, Farrell G, McCullagh L, Hennessy M, Clarke S, Mulcahy F, Bergin C, Role of individualization of hepatitis C virus (HCV) therapy duration in HIV/HCV-coinfected individuals., HIV medicine, 7, (4), 2006, p248-54
Schaffer K, Sheehy N, Coughlan S, Bergin C, Hall WW, JC virus in the Irish population: significant increase of genotype 2 in immunocompromised individuals., Journal of neurovirology, 12, (1), 2006, p39-46
Lesens O, Brannigan E, Bergin C, Christmann D, Hansmann Y, Impact of the use of aminoglycosides in combination antibiotic therapy on septic shock and mortality due to Staphylococcus aureus bacteremia., European journal of internal medicine, 17, (4), 2006, p276-80
Lyons F, Hopkins S, Kelleher B, McGeary A, Sheehan G, Geoghegan J, Bergin C, Mulcahy FM, McCormick PA, Maternal hepatotoxicity with nevirapine as part of combination antiretroviral therapy in pregnancy., HIV medicine, 7, (4), 2006, p255-60
Hopkins S, Coleman C, Kelleher M, Keating S, Clarke S, O'Connell B, Mulcahy F, Bergin C, Increasing resistance to ciprofloxacin among isolates of Neisseria gonorrhoea in Dublin., Irish medical journal, 98, (7), 2005, p208-9
A. Khalid, H. McDermott, C. Merry, C. Bergin., Eczema Herpeticum in a Patient with Atopic Dermatits Treated with Topical Tacrolimus., Irish Medical Journal, 2005, 98, 220
E. Devitt, R. Carroll, C. Donnelly, C Bergin., An unusual cause of abdominal pain, Irish Medical Journal, 2005
Lichterfeld M, Qurishi N, Hoffmann C, Hochdorfer B, Brockmeyer NH, Arasteh K, Mauss S, Rockstroh JK, Treatment of HIV-1-associated Kaposi's sarcoma with pegylated liposomal doxorubicin and HAART simultaneously induces effective tumor remission and CD4+ T cell recovery., Infection, 33, (3), 2005, p140-7
D Smith, V Ng, M Bonar, C Merry, C Bergin, MJ Cullen, JJ Nolan., Neurocysticercosis: a rare cause of seizure., Irish Medical Journal , 2004, 284, 285
Lesens O, Hansmann Y, Brannigan E, Remy V, Hopkins S, Martinot M, Meyer P, Connel BO, Monteil H, Christmann D, Bergin C, Positive surveillance blood culture is a predictive factor for secondary metastatic infection in patients with Staphylococcus aureus bacteraemia., The Journal of infection, 48, (3), 2004, p245-52
Hennessy M, Clarke S, Spiers JP, Mulcahy F, Kelleher D, Meadon E, Maher B, Bergin C, Khoo S, Tjia J, Hoggard P, Back D, Barry M, Intracellular indinavir pharmacokinetics in HIV-infected patients: comparison with plasma pharmacokinetics., Antiviral therapy, 8, (3), 2003, p191-8
Clarke S, Delamere S, McCullough L, Hopkins S, Bergin C, Mulcahy F, Assessing limiting factors to the acceptance of antiretroviral therapy in a large cohort of injecting drug users., HIV medicine, 4, (1), 2003, p33-7
Lesens O, Methlin C, Hansmann Y, Remy V, Martinot M, Bergin C, Meyer P, Christmann D, Role of comorbidity in mortality related to Staphylococcus aureus bacteremia: a prospective study using the Charlson weighted index of comorbidity., Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America, 24, (12), 2003, p890-6
P. Coakley, C. Bergin , Invasive Group A Streptococcal Infection, Epi-Insight, 2003
Boshoff C, Weiss R, AIDS-related malignancies., Nature reviews. Cancer, 2, (5), 2002, p373-82
Clarke S, Keenan E, Ryan M, Barry M, Mulcahy F, Directly observed antiretroviral therapy for injection drug users with HIV infection., The AIDS reader, 12, (7), 2002, p305-7, 312-6
F. Lyons, F. Mulcahy, C. Bergin., Screening for Genital Chlamydia trachomatis Infection in Women., Epi-Insight, 2001
Clarke S, Keenan E, Bergin C, Lyons F, Hopkins S, Mulcahy F, The changing epidemiology of HIV infection in injecting drug users in Dublin, Ireland., HIV medicine, 2, (4), 2001, p236-40
Hopkins S, Lyons F, Mulcahy F, Bergin C, The great pretender returns to Dublin, Ireland., Sexually transmitted infections, 77, (5), 2001, p316-8
S. Hopkins, C. Bergin, F. Mulcahy., Update: Syphilis Outbreak., Epi-Insight , 2001
S. Hopkins, C. Bergin, F. Mulcahy., An Outbreak of Syphilis in Dublin., Eurosurveillance Weekly, 2001
Kennedy M, O'Reilly M, Bergin CJ, McDonald GS, Liver biopsy pathology in human immunodeficiency virus infection., European journal of gastroenterology & hepatology, 10, (3), 1998, p255-8
Ward KE, McCarthy MW, Dapsone-induced methemoglobinemia., The Annals of pharmacotherapy, 32, (5), 1998, p549-53
D. Kane, C. Bergin, S. Keating, F. Mulcahy., 2nd International Congress on Drug Therapy in HIV Infection, Journal of European Academy of Dermato-Venereology, 1995, 301, 302
McCreary C, Bergin C, Pilkington R, Kelly G, Mulcahy F, Clinical parameters associated with recalcitrant oral candidosis in HIV infection: a preliminary study., International journal of STD & AIDS, 6, (3), 1995, p204-7
C. Bergin, F. Mulcahy. , Congress Report - First International Congress on Drug Therapy and HIV Infection, Journal of European Academy of Dermato-Venereology , 1993, 149, 150
C Bergin, M. Murphy, D. Lyons, E. Gaffney, F. Mulcahy., Toxoplasma Pneumonitis - A Fatal Presentation of Disseminated Toxoplasmosis in a Patient with AIDS., Eurpoean J of Resp Medicine , 1992, 1018, 1020
Nishimura J, Kobayashi S, Shikasho T, Kanaide H, Platelet-derived growth factor induces c-fos and c-myc mRNA in cultured rat aortic smooth muscle cells irrespective of intracellular Ca2+ levels., Japanese journal of pharmacology, 58 Suppl 2, 1992, p413P
Frazer RL, How to communicate quality to your patients., Dental management, 25, (11), 1985, p18-20, 22, 24
Tomin VP, [Education and demographic indices]., Zdravookhranenie Rossi"sko" Federatsii / Ministerstvo zdravookhraneniia RSFSR, (11), 1979, p11-7
J. Lambourne, N. Gibbons, J. Keane, C. Bergin , Simultaneous pulmonary and extrapulmonary infection by multiple strains of Mycobacterium tuberculosis infection in an immunocompromised patient, Jounal of Infection
AR Prior, J. Low, A. O Reilly, JG Parker, P. Daly, B. O Connell, C. Bergin, Community-Acquired Methicillin Resistant Panton Valentine Leukocidin Producing Staphylococcus Aureus Liver Abscess., Journal of Infection
AR Prior, J. Low, A. O Reilly, JG Parker, P. Daly, B. O Connell, C. Bergin, Community-Acquired Methicillin Resistant Panton Valentine Leukocidin Producing Staphylococcus Aureus Liver Abscess., Journal of Infection
Devitt E., Low J., Viner B., Bergin C., Clarke S., Weight based dosing of primaquine for Plasmodium vivax infection - a case for caution.
On-site Hepatitis C Treatment in a Specialist Drug Treatment Centre in Dublin, Keating S, O'Connor J, Keenan E, Nestor A, Bergin C
S Hopkins, M Abuzakouk, E Brannigan, C Feighery, C Bergin , Campylobacter jejuni cellulitis in an immunocompromised patient
I Collins, C. Bergin, S O Briain, D. O'Mahony, Hodgkin's Lymphoma in the Central Nervous System, Blood